Growth Metrics

Neurocrine Biosciences (NBIX) Change in Working Capital (2019 - 2020)

Neurocrine Biosciences (NBIX) has disclosed Change in Working Capital for 2 consecutive years, with $4.1 million as the latest value for Q1 2020.